Texas 2023 - 88th Regular

Texas House Bill HB3735 Latest Draft

Bill / Introduced Version Filed 03/06/2023

Download
.pdf .doc .html
                            88R11675 GCB-D
 By: Guerra H.B. No. 3735


 A BILL TO BE ENTITLED
 AN ACT
 relating to the administration of opioid antagonists by a school
 nurse at public school campuses.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  The heading to Subchapter E, Chapter 38,
 Education Code, is amended to read as follows:
 SUBCHAPTER E. MAINTENANCE, [AND] ADMINISTRATION, AND DISPOSAL OF
 EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND OPIOID
 ANTAGONISTS
 SECTION 2.  Section 38.201, Education Code, is amended by
 adding Subdivision (3-a) to read as follows:
 (3-a)  "Opioid antagonist" and "opioid-related drug
 overdose" have the meanings assigned by Section 483.101, Health and
 Safety Code.
 SECTION 3.  The heading to Section 38.208, Education Code,
 is amended to read as follows:
 Sec. 38.208.  MAINTENANCE, [AND] ADMINISTRATION, AND
 DISPOSAL OF EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND
 OPIOID ANTAGONISTS.
 SECTION 4.  Section 38.208, Education Code, is amended by
 adding Subsections (a-2) and (c-1) and amending Subsections (c) and
 (e) to read as follows:
 (a-2)  Each school district and open-enrollment charter
 school shall adopt and implement a policy authorizing a school
 nurse to maintain, administer, and dispose of an opioid antagonist
 at each campus of the district or school.
 (c)  The executive commissioner of the Health and Human
 Services Commission, in consultation with the commissioner of
 education, and with advice from the advisory committee as
 appropriate, shall adopt rules regarding:
 (1)  the maintenance, administration, and disposal of
 an epinephrine auto-injector at a school campus subject to a policy
 adopted under Subsection (a);
 (2)  [and] the maintenance and administration of asthma
 medicine at a school campus subject to a policy adopted under
 Subsection (a-1); and
 (3)  the maintenance, administration, and disposal of
 an opioid antagonist at a school campus in accordance with a policy
 adopted under Subsection (a-2).
 (c-1)  The rules adopted under Subsection (c) must
 establish:
 (1)  the number of epinephrine auto-injectors
 available at each campus;
 (2)  the amount of prescription asthma medicine
 available at each campus;
 (3)  the amount and type of opioid antagonists
 available at each campus;
 (4)  the process for a [each] school district,
 open-enrollment charter school, and private school, as applicable,
 to check the inventory of epinephrine auto-injectors, [and] asthma
 medicine, and opioid antagonists at regular intervals for
 expiration and replacement; and
 (5) [(4)]  the amount of training required for school
 personnel and school volunteers to administer an epinephrine
 auto-injector.
 (e)  The supply of epinephrine auto-injectors at each campus
 must be stored in a secure location and be easily accessible to
 school personnel and school volunteers authorized and trained to
 administer an epinephrine auto-injector.  The supply of asthma
 medicine and opioid antagonists at each campus must be stored in a
 secure location and be easily accessible to the school nurse.
 SECTION 5.  Section 38.209, Education Code, is amended to
 read as follows:
 Sec. 38.209.  REPORT ON ADMINISTERING EPINEPHRINE
 AUTO-INJECTOR OR OPIOID ANTAGONIST.  (a) Not later than the 10th
 business day after the date a school personnel member or school
 volunteer administers an epinephrine auto-injector in accordance
 with a policy adopted under Section 38.208(a), or a school nurse
 administers an opioid antagonist under Section 38.208(a-2), the
 school shall report the information required under Subsection (b)
 to:
 (1)  the school district, the charter holder if the
 school is an open-enrollment charter school, or the governing body
 of the school if the school is a private school, as applicable;
 (2)  the physician or other person who prescribed the
 epinephrine auto-injector or opioid antagonist; and
 (3)  the commissioner of state health services.
 (b)  The report required under this section must include the
 following information:
 (1)  the age of the person who received the
 administration of the epinephrine auto-injector or opioid
 antagonist;
 (2)  whether the person who received the administration
 of the epinephrine auto-injector or opioid antagonist was a
 student, a school personnel member or school volunteer, or a
 visitor, as applicable;
 (3)  the physical location where the epinephrine
 auto-injector or opioid antagonist was administered;
 (4)  the number of doses of epinephrine auto-injector
 or opioid antagonist administered;
 (5)  the title of the person who administered the
 epinephrine auto-injector or opioid antagonist; and
 (6)  any other information required by the commissioner
 of education.
 SECTION 6.  The heading to Section 38.211, Education Code,
 is amended to read as follows:
 Sec. 38.211.  PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS,
 [AND] ASTHMA MEDICINE, AND OPIOID ANTAGONISTS.
 SECTION 7.  Sections 38.211(a), (b), (c), (e), and (f),
 Education Code, are amended to read as follows:
 (a)  A physician or person who has been delegated
 prescriptive authority under Chapter 157, Occupations Code, may
 prescribe:
 (1)  epinephrine auto-injectors or asthma medicine in
 the name of a school district, open-enrollment charter school, or
 private school; or
 (2)  opioid antagonists in the name of a school
 district or open-enrollment charter school.
 (b)  A physician or other person who prescribes epinephrine
 auto-injectors, [or] asthma medicine, or opioid antagonists under
 Subsection (a) shall provide the school district, open-enrollment
 charter school, or private school with a standing order for the
 administration of, as applicable:
 (1)  an epinephrine auto-injector to a person
 reasonably believed to be experiencing anaphylaxis; [or]
 (2)  asthma medicine to a person reasonably believed to
 be experiencing a symptom of asthma and who has provided written
 notification and permission as required by Section 38.208(b-1); or
 (3)  an opioid antagonist to a person reasonably
 believed to be experiencing an opioid-related drug overdose.
 (c)  The standing order under Subsection (b) is not required
 to be patient-specific, and the epinephrine auto-injector, [or]
 asthma medicine, or opioid antagonist may be administered to a
 person without a previously established physician-patient
 relationship.
 (e)  An order issued under this section must contain:
 (1)  the name and signature of the prescribing
 physician or other person;
 (2)  the name of the school district, open-enrollment
 charter school, or private school to which the order is issued;
 (3)  the quantity of epinephrine auto-injectors, [or]
 asthma medicine, or opioid antagonists to be obtained and
 maintained under the order; and
 (4)  the date of issue.
 (f)  A pharmacist may dispense, without requiring the name or
 any other identifying information relating to the user:
 (1)  an epinephrine auto-injector or asthma medicine to
 a school district, open-enrollment charter school, or private
 school; or
 (2)  an opioid antagonist to a school district or
 open-enrollment charter school [without requiring the name or any
 other identifying information relating to the user].
 SECTION 8.  Section 38.215(a), Education Code, is amended to
 read as follows:
 (a)  A person who in good faith takes, or fails to take, any
 action under this subchapter is immune from civil or criminal
 liability or disciplinary action resulting from that action or
 failure to act, including:
 (1)  issuing an order for epinephrine auto-injectors,
 [or] asthma medicine, or opioid antagonists;
 (2)  supervising or delegating the administration of an
 epinephrine auto-injector or asthma medicine;
 (3)  possessing, maintaining, storing, or disposing of
 an epinephrine auto-injector, [or] asthma medicine, or opioid
 antagonist;
 (4)  prescribing an epinephrine auto-injector, [or]
 asthma medicine, or opioid antagonist;
 (5)  dispensing:
 (A)  an epinephrine auto-injector or opioid
 antagonist; or
 (B)  asthma medicine, provided that permission
 has been granted as provided by Section 38.208(b-1);
 (6)  administering, or assisting in administering:
 (A)  [,] an epinephrine auto-injector or opioid
 antagonist; or
 (B)  asthma medicine, provided that permission
 has been granted as provided by Section 38.208(b-1);
 (7)  providing, or assisting in providing, training,
 consultation, or advice in the development, adoption, or
 implementation of policies, guidelines, rules, or plans; or
 (8)  undertaking any other act permitted or required
 under this subchapter.
 SECTION 9.  This Act applies beginning with the 2023-2024
 school year.
 SECTION 10.  This Act takes effect immediately if it
 receives a vote of two-thirds of all the members elected to each
 house, as provided by Section 39, Article III, Texas Constitution.
 If this Act does not receive the vote necessary for immediate
 effect, this Act takes effect September 1, 2023.